550 filings
8-K
INO
Inovio Pharmaceuticals Inc
17 Apr 24
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:04pm
424B5
INO
Inovio Pharmaceuticals Inc
17 Apr 24
Prospectus supplement for primary offering
4:02pm
ARS
2023 FY
INO
Inovio Pharmaceuticals Inc
15 Apr 24
Annual report to shareholders
5:25pm
DEF 14A
INO
Inovio Pharmaceuticals Inc
Definitive proxy
11 Apr 24
4:10pm
10-K
2023 FY
INO
Inovio Pharmaceuticals Inc
Annual report
6 Mar 24
4:01pm
EFFECT
o0wpm msi64
1 Feb 24
Notice of effectiveness
12:15am
CORRESP
5t5ibc
29 Jan 24
Correspondence with SEC
12:00am
8-K
son7wkhk8totmp 8t0
25 Jan 24
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
2ewqg30dh8 8h46ndg
12 Jan 24
Submission of Matters to a Vote of Security Holders
5:27pm
UPLOAD
lotvghl7y
16 Nov 23
Letter from SEC
12:00am
8-K
xeaq20
9 Nov 23
INOVIO Reports Third Quarter 2023 Financial Results
4:15pm
8-K
2nilrz8
2 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
r5wmhg58bt
10 Oct 23
INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program
4:00pm
8-K
xtc6h8t
9 Aug 23
INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update
4:23pm